A61K 51/065
Conjugates with carriers being macromolecules
Official title: {conjugates with carriers being macromolecules}
A61K51/065 (Conjugates with carriers being macromolecules) appears on 182 US grants and 273 published applications in this corpus.
Search patents in A61K- Granted patents
- 182
- Published applications
- 273
- Assignees
- 178
- Inventors
- 660
- Latest grant
- 25 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1983 | 1 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 2 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 1 | 0 |
| 1993 | 1 | 0 |
| 1994 | 4 | 0 |
| 1995 | 3 | 0 |
| 1996 | 4 | 0 |
| 1997 | 6 | 0 |
| 1998 | 3 | 0 |
| 1999 | 5 | 0 |
| 2000 | 4 | 0 |
| 2001 | 6 | 2 |
| 2002 | 5 | 3 |
| 2003 | 4 | 17 |
| 2004 | 3 | 6 |
| 2005 | 5 | 3 |
| 2006 | 5 | 5 |
| 2007 | 3 | 7 |
| 2008 | 1 | 4 |
| 2009 | 1 | 2 |
| 2010 | 0 | 10 |
| 2011 | 3 | 6 |
| 2012 | 3 | 10 |
| 2013 | 6 | 13 |
| 2014 | 8 | 14 |
| 2015 | 13 | 13 |
| 2016 | 4 | 15 |
| 2017 | 12 | 12 |
| 2018 | 12 | 16 |
| 2019 | 8 | 17 |
| 2020 | 11 | 15 |
| 2021 | 9 | 17 |
| 2022 | 7 | 18 |
| 2023 | 3 | 14 |
| 2024 | 6 | 15 |
| 2025 | 2 | 10 |
| 2026 | 7 | 9 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- DOTA-hapten compositions for anti-DOTA/anti-tumor antigen bispecific antibody pretargeted radioimmunotherapy25 Aug 2026US 12,714,758 B2Memorial Sloan Kettering Cancer Center
- Cross-linking compounds and methods of use thereof30 Jun 2026US 12,668,646 B2North Carolina State University
- Trifunctional constructs with tunable pharmacokinetics useful in imaging and anti-tumor therapies23 Jun 2026US 12,661,417 B2Cornell University
- Peptide receptor radionuclide therapy9 Jun 2026US 12,649,008 B2The Regents of the University of California
- Synthesis of uniformly defined molecular weight mannosylated dextrans and derivatives thereof24 Mar 2026US 12,583,945 B2Navidea Biopharmaceuticals, Inc.
- Development of a platform to noninvasively image car t cells8 Oct 2026US 2026/0306681 A1Dana-Farber Cancer Institute, Inc.
- Trifunctional constructs with tunable pharmacokinetics useful in imaging and anti-tumor therapies17 Sep 2026US 2026/0273111 A1Cornell University
- Compositions and methods for targeting tumor-associated macrophages13 Aug 2026US 2026/0232850 A1Resolute Science
- Conjugates having antifouling nanoparticles and methods of use9 Jul 2026US 2026/0191997 A1Board of Regents, The University of Texas System
- Synthesis of uniformly defined molecular weight mannosylated dextrans and derivatives thereof9 Jul 2026US 2026/0193382 A1Cardinal Health 414, LLC
Most cited
By later US patents
- Polychelating agents for image and spectral enhancement (and spectral shift)138US 5,155,215 AAccess Pharmaceuticals, Inc. · 1992
- System for targeted delivery of therapeutic agents127US 8,709,483 B2Massachusetts Institute of Technology · 2014
- Water soluble paclitaxel derivatives122US 6,730,699 B2PG-TXL Company, L. P. · 2004
- Targeted diagnostic/therapeutic agents having more than one different vectors95US 6,331,289 B1Nycomed Imaging AS · 2001
- Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations thereof93US 8,668,926 B12014